Kevin MacDonald

Kit Check, Inc. engages in the provision of automated hospital pharmacy kit processing and medication tracking software. Its software tracks RFID tags used on medication in hospitals, limiting human error, and helping hospitals plan ahead. It also offers Bluesight for Controlled Substances, a controlled substance tracking and drug diversion detection software solution which offers complete coverage of the OR, nursing floors, and other hospital procedural areas. The company was founded by by Timothy Kress-Spatz and Kevin MacDonald in 2011 and is headquartered in Washington, DC.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.